FDA Expands Recalls of Blood Pressure, Heart Drugs Over Cancer Concerns - NBC Connecticut

Important News on Consumer Products That Can Keep You Safe

FDA Expands Recalls of Blood Pressure, Heart Drugs Over Cancer Concerns

The FDA is urging patients to look at the name of the drug and company on the label of a prescription bottle to determine whether the medication has been recalled

    processing...

    NEWSLETTERS

    Connect to Healthier
    Joe Raedle/Getty Images
    File photo of a doctor reading a blood pressure gauge during an examination of a patient.

    What to Know

    • The FDA expanded its list of recalled products and updated its list of those unaffected

    • Traces of N-nitrosodimethylamine, a "probable human carcinogen," was found in the active ingredient valsartan in the recalled products

    • Not all products containing valsartan are contaminated and being recalled

    The U.S. Food and Drug Administration has expanded its voluntary recall of several medications used to treat high blood pressure and heart failure over concerns that an active ingredient in the drugs could be contaminated with a cancer-causing agent.

    The agency reported that traces of N-nitrosodimethylamine (NDMA), a "probable human carcinogen," was found in the active ingredient valsartan in the recalled products. The FDA noted not all products containing valsartan are contaminated and being recalled. A third-party supplied the valsartan contained in the recall. 

    The FDA updated the list of products included in the recall and the list of those unaffected

    "FDA is working with drug manufacturers to ensure future valsartan active pharmaceutical ingredients are not at risk of NDMA formation," the FDA said. "The agency reminds manufacturers to thoroughly evaluate their API manufacturing processes, and changes to those processes, to detect any unsafe impurities."

    Avalanche Buries Unknown Number of People in NM

    [NATL] Avalanche Buries Unknown Number of People in NM

    Ski Patrol and first responders are working to rescue an unknown number of skiers buried in an avalanche at Taos Ski Resort in New Mexico

    (Published Thursday, Jan. 17, 2019)

    Patients are urged to look at the drug name and company name on the label of their prescription bottle to determine whether a specific product has been recalled. If the information is not on the bottle, patients should contact the pharmacy that dispensed the medicine to find out the company name.

    If a patient is taking one of the recalled medicines, they should follow the recall instructions each specific company provided, which will be available on the FDA’s website.

    If a patient's medicine is included in the recall, they should contact their health care professional to discuss their treatment options, which may include another valsartan product this recall doesn't affect or an alternative option.

    The agency encourages patients and health care professionals to report any adverse reaction to the FDA’s MedWatch program.

    "The FDA’s review is ongoing and has included investigating the levels of NDMA in the recalled products, assessing the possible effect on patients who have been taking them and what measures can be taken to reduce or eliminate the impurity from future batches produced by the company," the FDA said in a news release.

    The presence of NDMA is "thought to be related to changes in the way the active substance was manufactured," the agency said.

    Iowa Man Gets "Jackpot Treatment" for $1 Lotto Ticket Win

    [NATL] Iowa Man Gets "Jackpot Treatment" for $1 Lotto Ticket Win

    An Iowa man got the "Jackpot treatment" after winning $1 off a scratch-off lotto ticket. Tyler Heep decided to cash in the winning ticket at the Iowa Lottery Headquarters and was presented with a big check for his win. Heep spent his winnings on a gallon of gas.

    (Published Friday, Jan. 18, 2019)